Stage III Breast Cancer Recruiting Phase 1 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs